» Articles » PMID: 10998390

Antimicrobial-drug Use and Changes in Resistance in Streptococcus Pneumoniae

Overview
Date 2000 Sep 22
PMID 10998390
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Resistance of Streptococcus pneumoniae to antimicrobial drugs is increasing. To investigate the relationship between antimicrobial use and susceptibility of S. pneumoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of these centers. We found an association between decreased penicillin susceptibility and use of beta-lactam antimicrobial drugs.

Citing Articles

Population structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern Gambia.

Ashu E, Jarju S, Dione M, Mackenzie G, Ikumapayi U, Manjang A BMC Infect Dis. 2016; 16:33.

PMID: 26822883 PMC: 4731921. DOI: 10.1186/s12879-016-1370-0.


Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico.

Santa-Ana-Tellez Y, Mantel-Teeuwisse A, Dreser A, Leufkens H, Wirtz V PLoS One. 2013; 8(10):e75550.

PMID: 24146761 PMC: 3797702. DOI: 10.1371/journal.pone.0075550.


Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.

Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L J Infect Dis. 2013; 208(8):1266-73.

PMID: 23852588 PMC: 3778966. DOI: 10.1093/infdis/jit315.


Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.

Van Eldere J, Mera R, Miller L, Poupard J, Amrine-Madsen H Antimicrob Agents Chemother. 2007; 51(10):3491-7.

PMID: 17682102 PMC: 2043272. DOI: 10.1128/AAC.01581-06.


Community prescribing and resistant Streptococcus pneumoniae.

Barkai G, Greenberg D, Givon-Lavi N, Dreifuss E, Vardy D, Dagan R Emerg Infect Dis. 2005; 11(6):829-37.

PMID: 15963276 PMC: 3367585. DOI: 10.3201/eid1106.050198.


References
1.
Muscato J, WILBUR D, Stout J, Fahrlender R . An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage. J Antimicrob Chemother. 1991; 27 Suppl C:1-7. DOI: 10.1093/jac/27.suppl_c.1. View

2.
Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L . Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987; 317(1):18-22. DOI: 10.1056/NEJM198707023170104. View

3.
Gerding D, Larson T . Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985. Am J Med. 1986; 80(6B):22-8. DOI: 10.1016/0002-9343(86)90475-4. View

4.
Pradier C, Dunais B, Carsenti-Etesse H, Dellamonica P . Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis. 1997; 16(9):644-7. DOI: 10.1007/BF01708553. View

5.
Gaynes R . The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am. 1998; 11(4):757-65. DOI: 10.1016/s0891-5520(05)70388-3. View